Truvestments Capital’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $37.6K | Hold |
|
|||||
|
2025
Q1 | $33.1K | Sell |
|
|||||
|
2024
Q4 | $76.2K | Buy |
|
|||||
|
2024
Q3 | $62.7K | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $78.1K | Buy |
|
|||||
|
2023
Q4 | $35.3K | Hold |
|
|||||
|
2023
Q3 | $30.1K | Hold |
|
|||||
|
2023
Q2 | $25.3K | Hold |
|
|||||
|
2023
Q1 | $27.1K | Hold |
|
|||||
|
2022
Q4 | $32K | Sell |
|
|||||
|
2022
Q3 | $118K | Hold |
|
|||||
|
2022
Q2 | $108K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $104K | Buy |
|
|||||
|
2021
Q3 | $99K | Buy |
|
|||||
|
2021
Q2 | $97K | Buy |
|
|||||
|
2021
Q1 | $75K | Buy |
|
|||||
|
2020
Q4 | $26K | Buy |
|
|||||
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $9K | Buy |
|
|||||
|
2020
Q1 | $5K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $3K | Buy |
|